137 related articles for article (PubMed ID: 37170541)
21. Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours.
Saani I; Raj N; Sood R; Ansari S; Mandviwala HA; Sanchez E; Boussios S
Int J Environ Res Public Health; 2023 Jun; 20(12):. PubMed ID: 37372675
[TBL] [Abstract][Full Text] [Related]
22. Superinfection of mature ovarian cystic teratoma in a child: An unusual presentation.
Chhabra A; Galhotra S; Nibhoria S
J Cancer Res Ther; 2018; 14(5):1154-1156. PubMed ID: 30197369
[TBL] [Abstract][Full Text] [Related]
23. Germ cell tumors of the ovary: a clinicopathologic study of 121 cases from Nepal.
Sah SP; Uprety D; Rani S
J Obstet Gynaecol Res; 2004 Aug; 30(4):303-8. PubMed ID: 15238107
[TBL] [Abstract][Full Text] [Related]
24. Laparotomy for post chemotherapy residue in ovarian germ cell tumors.
Mathew GK; Singh SS; Swaminathan RG; Tenali SG
J Postgrad Med; 2006; 52(4):262-5. PubMed ID: 17102543
[TBL] [Abstract][Full Text] [Related]
25. Malignant Gonadal Germ Cell Tumors (Other Than Pure Germinoma) in Patients With Disorders of Sex Development: A Report of 21 Cases Based Largely on the Collection of Dr Robert E. Scully, Illustrating a High Frequency of Yolk Sac Tumor With Prominent Hepatoid and Glandular Features.
Segura SE; Young RH; Oliva E; Ulbright TM
Am J Surg Pathol; 2022 May; 46(5):664-676. PubMed ID: 34560684
[TBL] [Abstract][Full Text] [Related]
26. Utility of frozen section in pediatric and adolescent malignant ovarian nonseminomatous germ cell tumors: A report from the children's oncology group.
Dicken BJ; Billmire DF; Rich B; Hazard FK; Nuño M; Krailo M; Fallahazad N; Pashankar F; Shaikh F; Frazier AL
Gynecol Oncol; 2022 Sep; 166(3):476-480. PubMed ID: 35750503
[TBL] [Abstract][Full Text] [Related]
27. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
[TBL] [Abstract][Full Text] [Related]
28. Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence.
Topuz S; Iyibozkurt AC; Akhan SE; Keskin N; Yavuz E; Salihoglu Y; Bengisu E; Berkman S
Eur J Gynaecol Oncol; 2008; 29(6):635-7. PubMed ID: 19115694
[TBL] [Abstract][Full Text] [Related]
29. ZBTB16: a novel sensitive and specific biomarker for yolk sac tumor.
Xiao GQ; Li F; Unger PD; Katerji H; Yang Q; McMahon L; Burstein DE
Mod Pathol; 2016 Jun; 29(6):591-8. PubMed ID: 26916077
[TBL] [Abstract][Full Text] [Related]
30. Malignant Germ Cell Tumors of the Ovary: Clinical and Imaging Features.
Rogers D; Menias C; Shaaban A
Radiol Clin North Am; 2023 Jul; 61(4):579-594. PubMed ID: 37169425
[TBL] [Abstract][Full Text] [Related]
31. NUT protein immunoreactivity in ovarian germ cell tumours.
Iacobelli JF; Charles AK; Crook M; Stewart CJ
Pathology; 2015 Feb; 47(2):118-22. PubMed ID: 25551299
[TBL] [Abstract][Full Text] [Related]
32. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
[TBL] [Abstract][Full Text] [Related]
33. Blood group-related antigens in human germ cell tumors.
Motzer RJ; Reuter VE; Cordon-Cardo C; Bosl GJ
Cancer Res; 1988 Sep; 48(18):5342-7. PubMed ID: 3044584
[TBL] [Abstract][Full Text] [Related]
34. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
Qin B; Xu W; Li Y
Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
[TBL] [Abstract][Full Text] [Related]
35. Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors.
Solheim O; Førsund M; Tropé CG; Kraggerud SM; Nesland JM; Davidson B
APMIS; 2017 Sep; 125(9):781-786. PubMed ID: 28585395
[TBL] [Abstract][Full Text] [Related]
36. Intracranial germ cell tumors: pathobiological and immunohistochemical aspects of 70 cases.
Bjornsson J; Scheithauer BW; Okazaki H; Leech RW
J Neuropathol Exp Neurol; 1985 Jan; 44(1):32-46. PubMed ID: 4038412
[TBL] [Abstract][Full Text] [Related]
37. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis.
He L; Ding H; Wang JH; Zhou Y; Li L; Yu YH; Huang L; Jia WH; Zeng M; Yun JP; Luo RZ; Zheng M
PLoS One; 2012; 7(9):e42992. PubMed ID: 22962582
[TBL] [Abstract][Full Text] [Related]
39. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
[TBL] [Abstract][Full Text] [Related]
40. Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.
Yu XJ; Zhang L; Liu ZP; Shi YQ; Liu YX
Int J Clin Exp Pathol; 2014; 7(12):8996-9001. PubMed ID: 25674278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
